Categoria: Biobank Law



The Last Act of the Gene Patents (?)

The US Supreme Court has recently written the last chapter of the “Myriad trilogy”. The issue at stake was about the patentatibility of the sequence of BRCA-1 and BRCA-2 linked to breast and ovarian cancer. The...

News from Spain

  Published in BOE (Boletin Oficial del Estado) the “Real Decreto” about biobanks. real_decreto_biobancos.pdf

News: Brüstle v Greenpeace

In this recent case, the ECJ was asked for a preliminary ruling on the interpretation of Article 6 (2) (c) of Directive 98/44/EC on the legal protection of biotechnological inventions. Adopting a broad definition of embryo,...

Myriad Case: The Empire strokes back (?)

  The Court of Appeal for the Federal Circuit riversed the decision made by the District Court of New York. The latter invalidated the patent owned by Myriad Genetics and the University of Utah Research Foundation...


       IL SOLE 24 ORE – SANITA’ – 19 OTTOBRE 2010 Di Umberto Izzo e Matteo Macilotti,  RISCHIO PARALISI DAL NUOVO CODICE SUI BREVETTI L’ultima mossa del legislatore italiano